Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinqi Bio, operating globally under the brand Bio-Growing, is a leading Chinese biotechnology company specializing in the research, development, and manufacturing of probiotic strains. Founded in 2006, the company maintains an extensive microbial strain library and operates state-of-the-art fermentation facilities that comply with international GMP standards. Their business model encompasses the production of bulk probiotic powders, customized formulation development, and full-service contract manufacturing (CDMO) for dietary supplements. In 2023, the company was acquired by IFF (International Flavors & Fragrances) to strengthen its microbiome capabilities in the Asia-Pacific region. Jinqi Bio serves a diverse global clientele, exporting products to over 60 countries for applications in human health and nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinqi Bio Group.